What is the current Hepatitis B and C Detection Kits market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Hepatitis B and C Detection Kits market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Hepatitis B and C Detection Kits market?

Increasing prevalence of hepatitis and advancements in diagnostic technologies drive the market.

What challenges does the Hepatitis B and C Detection Kits market face?

High costs and limited awareness in developing regions hinder market growth.

Which regions lead the Hepatitis B and C Detection Kits market?

North America and Europe are the leading regions due to high awareness and diagnostic rates.

Who are the top companies in the Hepatitis B and C Detection Kits market?

Leading companies include Abbott, Roche, and Siemens, offering innovative diagnostic solutions.

What future opportunities exist in the Hepatitis B and C Detection Kits market?

Emerging economies and point-of-care diagnostics present significant future outlook opportunities.

How does technology impact the Hepatitis B and C Detection Kits market?

Advances in molecular diagnostics and automation enhance detection accuracy and efficiency.

What is the regulatory landscape like for the Hepatitis B and C Detection Kits market?

Stringent regulations and standards ensure diagnostic kit quality and safety.

What is the future outlook for the Hepatitis B and C Detection Kits market size?

The market is expected to reach USD 2.5 billion by 2033, driven by increasing demand.

Hepatitis B and C Detection Kits Industry Trends & Competitive Analysis 2033

Hepatitis B and C Detection Kits by Application (Online Pharmacy, Hospital, Clinic, Others), by Types (Hepatitis B Detection Kits, Hepatitis C Detection Kits), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.1 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.1 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Hepatitis B and C Detection Kits Market Size | CAGR 7.2 Forecast 2033

Hepatitis B and C Detection Kits Industry Trends & Competitive Analysis 2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.1 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.1 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Hepatitis B and C Detection Kits Market Overview

The Hepatitis B and C Detection Kits market refers to the industry involved in the development and distribution of diagnostic kits for the detection of Hepatitis B and C viruses. As the Hepatitis B and C Detection Kits market size is estimated to be around $2.5 billion, the growth outlook and market forecast suggest a significant expansion of the industry. The industry expansion is driven by the increasing prevalence of Hepatitis B and C infections, advancements in diagnostic technologies, and growing awareness about the importance of early detection and treatment. The scope of the market includes various types of detection kits, such as enzyme-linked immunosorbent assay (ELISA) kits, rapid diagnostic test (RDT) kits, and polymerase chain reaction (PCR) kits, which are used in hospitals, clinics, and research institutions.

Loading chart…

The Hepatitis B and C Detection Kits market is expected to grow at a compound annual growth rate (CAGR) of around 8-10% during the forecast period from 2026 to 2033. The growth is driven by factors such as technology shifts towards more advanced and accurate diagnostic techniques, regulations supporting the use of diagnostic kits, and consumer behavior emphasizing early detection and treatment. The largest region in the market is North America, while the fastest-growing region is Asia-Pacific. Key forces shaping the industry include the increasing adoption of point-of-care (POC) diagnostics, the rising demand for non-invasive diagnostic techniques, and the growing competition among market players.

Report Overview

Report Attribute	Details
Market size value in 2025	8.10 million
Revenue forecast in 2033	14.13 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ACON Laboratories; Biopanda Reagents; Grifols; SD Biosensor; JOYSBIO (Tianjin) Biotechnology; Guangzhou Biotron Technology; Taipu Bioscience; JAL Medical and JAL Innovation; Fujirebio; ATTOPLEX; DiaSorin; Boditech Med; AccuBioTech; InTec; Standard Diagnostics; Bioeasy Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Hepatitis B and C Detection Kits market is poised for significant growth, driven by various factors that are expected to shape its trajectory. Understanding the dynamics at play is crucial for stakeholders to navigate this complex landscape effectively.

Growth Drivers2 items

Advancements in diagnostic technologies, such as next-generation sequencing and point-of-care testing, are enhancing the accuracy and accessibility of Hepatitis B and C Detection Kits, thereby driving the growth of the Hepatitis B and C Detection Kits market size.

Increasing awareness and screening programs, particularly in regions with high prevalence rates, contribute to the upward trend in the Hepatitis B and C Detection Kits market, influencing the growth forecast.

Restraints2 items

Stringent regulatory frameworks and the need for FDA approvals can delay the launch of new Hepatitis B and C Detection Kits, potentially hindering market growth and impacting the overall Hepatitis B and C Detection Kits market size.

High costs associated with some diagnostic kits can limit their adoption in resource-constrained settings, affecting the growth forecast of the Hepatitis B and C Detection Kits market.

Opportunities2 items

Emerging markets, particularly in Asia-Pacific and Latin America, present opportunities for expansion due to their large patient populations and growing demand for effective diagnostic solutions, contributing to the growth of the Hepatitis B and C Detection Kits market.

The development of point-of-care and home-based testing solutions offers opportunities for companies to tap into the growing demand for convenient and user-friendly diagnostic tools, influencing the Hepatitis B and C Detection Kits market size.

Challenges2 items

The Hepatitis B and C Detection Kits market faces challenges related to the availability of skilled personnel to operate complex diagnostic equipment, which can hinder the adoption of these kits and impact the growth forecast.

Competition from alternative diagnostic methods and the need for continuous innovation to stay ahead in the market pose significant challenges for manufacturers of Hepatitis B and C Detection Kits, affecting the overall market dynamics.

Market Segmentation

Loading chart…

The Hepatitis B and C Detection Kits market can be segmented based on Application, which includes Hospitals, Diagnostic Centers, Research Institutes, and Blood Banks. This segmentation contributes to the overall market size as different applications have varying demands for detection kits, driving the market growth. The Hepatitis B and C Detection Kits segmentation is crucial in understanding the market dynamics and trends.

Based on Types, the Hepatitis B and C Detection Kits market can be further divided into Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Reaction (PCR), and Next-Generation Sequencing (NGS). Each type has its own set of subtypes, such as [object Object],[object Object], which cater to specific needs and preferences of end-users, ultimately influencing the market size and taxonomy.

Hepatitis B and C Detection Kits Segmentation Breakdown8 items

Application

Online Pharmacy

Hospital

Clinic

Others

Types

Hepatitis B Detection Kits

Hepatitis C Detection Kits

Regional Insights

Loading chart…

The Hepatitis B and C Detection Kits market growth is expected to be driven by various regional factors. The largest region, Asia Pacific, accounts for approximately 40% of the market share, driven by key drivers such as increasing adoption of advanced diagnostic technologies, government policies supporting healthcare infrastructure development, and significant investments in research and development. The fastest-growing region, Latin America, is expected to witness significant growth due to rising demographics and growing infrastructure in the healthcare sector.

In North America, key drivers include high ecosystem maturity, significant investments in healthcare innovation, and favorable policies supporting the development of advanced diagnostic technologies. Europe is driven by factors such as increasing adoption of point-of-care diagnostic solutions, growing infrastructure in the healthcare sector, and significant investments in research and development. Middle East & Africa is expected to witness growth due to rising demographics and growing infrastructure in the healthcare sector, although it currently accounts for a relatively small share of the market.

Competitive Landscape

The Hepatitis B and C Detection Kits market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Hepatitis B and C Detection Kits competitive landscape is driven by the need for accurate and reliable diagnostic tools, with key players focusing on product differentiation and strategic partnerships to maintain market share. Global players are expanding their presence in emerging markets, while local companies are leveraging their regional expertise to compete with international firms.

Companies in this market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantage. To stay ahead, companies must focus on innovation, technology, and service model differentiation, while managing supply chain risks and maintaining cost advantages. The following companies are examples of this:

ACON Laboratories: regional expansion

Biopanda Reagents: premium pricing

Grifols: vertical integration

SD Biosensor: innovation pipeline

JOYSBIO: local manufacturing

Fujirebio: OEM tie-ups

Key Hepatitis B and C Detection Kits Companies16 items

ACON Laboratories

Biopanda Reagents

Grifols

SD Biosensor

JOYSBIO (Tianjin) Biotechnology

Guangzhou Biotron Technology

Taipu Bioscience

JAL Medical and JAL Innovation

Fujirebio

ATTOPLEX

DiaSorin

Boditech Med

AccuBioTech

InTec

Standard Diagnostics

Bioeasy Biotechnology

Market Ecosystem

The Hepatitis B and C Detection Kits ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of detection kits, with each segment influencing the overall efficiency and effectiveness of the ecosystem. The ecosystem boundaries are defined by the interactions between these segments, from raw material suppliers to end users, with each player contributing to the creation and delivery of Hepatitis B and C detection solutions.

Raw material suppliers — providing components for kit assembly

OEMs / manufacturers — producing detection kits

Technology providers — developing diagnostic technologies

Distributors / channel partners — delivering kits to healthcare facilities

Service providers / after-sales — offering maintenance and support services

End users / buyers — utilizing detection kits for diagnostic purposes

Regulators/standards bodies — establishing guidelines and approvals for kit usage

In the Hepatitis B and C Detection Kits ecosystem, control points are influenced by regulators and standards bodies, as well as technology providers and manufacturers. Dependency risks arise from input constraints, such as component availability, and standards approvals, which can impact the adoption of detection kits. Switching costs and partnerships between ecosystem participants can also affect the overall efficiency of the ecosystem. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and healthcare infrastructure, highlighting the need for a thorough value chain analysis to understand the complex interactions within the Hepatitis B and C Detection Kits ecosystem.

Recent Industry Insights

The Hepatitis B and C Detection Kits industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between major diagnostic companies to develop innovative detection kits, have been a key focus area. Additionally, there have been notable mergers and acquisitions, including the acquisition of a leading diagnostic firm by a prominent player in the industry.

Furthermore, the launch of advanced detection technologies and point-of-care testing solutions has transformed the Hepatitis B and C Detection Kits market. Regulatory changes, such as the implementation of stricter guidelines for diagnostic kit manufacturing, have also had a profound impact. The industry has seen a shift in consumer trends, with an increasing demand for rapid and accurate detection kits. Funding rounds and expansions have also been observed, with key players investing heavily in research and development to stay ahead in the market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Hepatitis B and C Detection Kits market. The market attractiveness is high due to the increasing prevalence of hepatitis B and C, driving demand for effective detection kits. The competitive intensity is moderate, with key players investing in research and development to improve kit sensitivity and specificity. The long-term outlook for the Hepatitis B and C Detection Kits market outlook is positive, driven by advancements in technology and rising awareness about hepatitis prevention.

The innovation landscape is evolving, with a focus on point-of-care testing and molecular diagnostics. However, the demand–supply balance may be affected by key risk factors, including regulatory changes and supply chain disruptions. Overall, our analysis provides valuable insights for decision-makers to navigate the complex Hepatitis B and C Detection Kits market.

11 items

1. Executive Summary

2. Hepatitis B and C Detection Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Hepatitis B and C Detection Kits Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Hepatitis B and C Detection Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Online Pharmacy

6.1.2. Hospital

6.1.3. Clinic

6.1.4. Others

6.2. Global Hepatitis B and C Detection Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Hepatitis B Detection Kits

6.2.2. Hepatitis C Detection Kits

6.3. Global Hepatitis B and C Detection Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Hepatitis B and C Detection Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Hepatitis B and C Detection Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Hepatitis B and C Detection Kits Market Competition by Key Manufacturers

8.1. Global Hepatitis B and C Detection Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Hepatitis B and C Detection Kits: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. ACON Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Biopanda Reagents

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Grifols

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. SD Biosensor

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. JOYSBIO (Tianjin) Biotechnology

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Guangzhou Biotron Technology

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Taipu Bioscience

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. JAL Medical and JAL Innovation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Fujirebio

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. ATTOPLEX

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. DiaSorin

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Boditech Med

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. AccuBioTech

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. InTec

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Standard Diagnostics

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Bioeasy Biotechnology

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Hepatitis B and C Detection Kits Market

Figure 4: Global Hepatitis B and C Detection Kits Market: Drivers

Figure 5: Global Hepatitis B and C Detection Kits Market: Challenges

Figure 6: Global Hepatitis B and C Detection Kits Market: Trends

Figure 7: Global Hepatitis B and C Detection Kits Market: Opportunity

Figure 8: Global Hepatitis B and C Detection Kits Market: Restraint

Figure 9: Global Hepatitis B and C Detection Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Hepatitis B and C Detection Kits Market Value (USD Million) By Region

Figure 15: Global Hepatitis B and C Detection Kits Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Hepatitis B and C Detection Kits Market Value (USD Million) By Region

Figure 23: Global Hepatitis B and C Detection Kits Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Hepatitis B and C Detection Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Hepatitis B and C Detection Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Hepatitis B and C Detection Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Hepatitis B and C Detection Kits Market Value (USD Million) By Region

Table 10: Global Hepatitis B and C Detection Kits Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Hepatitis B and C Detection Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Hepatitis B and C Detection Kits Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Hepatitis B and C Detection Kits Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: ACON Laboratories Basic Information And Sales Area

Table 31: ACON Laboratories. Products Portfolio

Table 32: Biopanda Reagents Basic Information And Sales Area

Table 33: Biopanda Reagents. Products Portfolio

Table 34: Grifols Basic Information And Sales Area

Table 35: Grifols. Products Portfolio

Table 36: SD Biosensor Basic Information And Sales Area

Table 37: SD Biosensor. Products Portfolio

Table 38: JOYSBIO (Tianjin) Biotechnology Basic Information And Sales Area

Table 39: JOYSBIO (Tianjin) Biotechnology. Products Portfolio

Table 40: Guangzhou Biotron Technology Basic Information And Sales Area

Table 41: Guangzhou Biotron Technology. Products Portfolio

Table 42: Taipu Bioscience Basic Information And Sales Area

Table 43: Taipu Bioscience. Products Portfolio

Table 44: JAL Medical and JAL Innovation Basic Information And Sales Area

Table 45: JAL Medical and JAL Innovation. Products Portfolio

Table 46: Fujirebio Basic Information And Sales Area

Table 47: Fujirebio. Products Portfolio

Table 48: ATTOPLEX Basic Information And Sales Area

Table 49: ATTOPLEX. Products Portfolio

Table 50: DiaSorin Basic Information And Sales Area

Table 51: DiaSorin. Products Portfolio

Table 52: Boditech Med Basic Information And Sales Area

Table 53: Boditech Med. Products Portfolio

Table 54: AccuBioTech Basic Information And Sales Area

Table 55: AccuBioTech. Products Portfolio

Table 56: InTec Basic Information And Sales Area

Table 57: InTec. Products Portfolio

Table 58: Standard Diagnostics Basic Information And Sales Area

Table 59: Standard Diagnostics. Products Portfolio

Table 60: Bioeasy Biotechnology Basic Information And Sales Area

Table 61: Bioeasy Biotechnology. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Hepatitis B and C Detection Kits Market Value (USD Million) By Region

Table 67: Global Hepatitis B and C Detection Kits Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Hepatitis B and C Detection Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.10 million
Revenue forecast in 2033	14.13 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ACON Laboratories; Biopanda Reagents; Grifols; SD Biosensor; JOYSBIO (Tianjin) Biotechnology; Guangzhou Biotron Technology; Taipu Bioscience; JAL Medical and JAL Innovation; Fujirebio; ATTOPLEX; DiaSorin; Boditech Med; AccuBioTech; InTec; Standard Diagnostics; Bioeasy Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options